Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference
| SEER Stock | USD 2.41 0.04 1.63% |
Slightly above 61% of Seer's investor base is looking to short. The analysis of overall sentiment of trading Seer Inc stock suggests that many investors are alarmed at this time. Seer's investing sentiment overview a quick insight into current market opportunities from investing in Seer Inc. Many technical investors use Seer Inc stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Seer |
REDWOOD CITY, Calif., Jan. 02, 2025 -- Seer, Inc. , a leading life sciences company commercializing a disruptive new platform for prot
Read at gurufocus.com
 |
Seer Fundamental Analysis
We analyze Seer's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Seer using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Seer based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Number Of Employees
Number Of Employees Comparative Analysis
Seer is currently under evaluation in number of employees category among its peers. Number of Employees shows the total number of permanent full time and part time employees working for a given company and processed through its payroll.
Seer Inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Seer stock to make a market-neutral strategy. Peer analysis of Seer could also be used in its relative valuation, which is a method of valuing Seer by comparing valuation metrics with similar companies.
Peers
Seer Related Equities
| SANA | Sana Biotechnology | 160.61 | ||||
| NRIX | Nurix Therapeutics | 3.23 | ||||
| MOLN | Molecular Partners | 0.55 | ||||
| CCCC | C4 Therapeutics | 0.52 | ||||
| ANEB | Anebulo Pharmaceuticals | 0.61 | ||||
| FHTX | Foghorn Therapeutics | 0.85 | ||||
| KYMR | Kymera Therapeutics | 0.98 | ||||
| PEPG | PepGen | 1.15 | ||||
| NKTX | Nkarta | 1.24 | ||||
| LYEL | Lyell Immunopharma | 1.52 | ||||
| HCWB | HCW Biologics | 2.44 | ||||
| STTK | Shattuck Labs | 3.15 | ||||
| PHVS | Pharvaris | 3.59 | ||||
| ANTX | AN2 Therapeutics | 3.70 | ||||
| CGEM | Cullinan Oncology | 3.72 | ||||
| MNOV | MediciNova | 5.24 | ||||
| ORIC | Oric Pharmaceuticals | 7.81 | ||||
| GLUE | Monte Rosa | 8.27 | ||||
| GBIO | Generation Bio | 12.50 | ||||
| MLYS | Mineralys Therapeutics, | 13.71 | ||||
| QSI | QuantumSi | 24.57 |
Additional Tools for Seer Stock Analysis
When running Seer's price analysis, check to measure Seer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seer is operating at the current time. Most of Seer's value examination focuses on studying past and present price action to predict the probability of Seer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seer's price. Additionally, you may evaluate how the addition of Seer to your portfolios can decrease your overall portfolio volatility.